Variables | Vitamin K2 group | Placebo group | P-value2 |
---|---|---|---|
Number | 32 | 31 | – |
Age, years | 56.8 ± 7.34 | 58.2 ± 7.39 | 0.440 |
Disease duration, years | 7.81 ± 4.27 | 9.68 ± 5.93 | 0.156 |
Female, n (%) | 21 (65.6%) | 18 (58.1%) | 0.609 |
Smokers, n (%) | 5 (15.6%) | 2 (6.5%) | 0.426 |
Academic education, n (%) | 7 (21.9%) | 14 (45.1%) | 0.201 |
Weight, kg | 7.29 ± 14.7 | 74.9 ± 16.7 | 0.607 |
Body mass index, kg/m2 | 27.9 ± 4.90 | 27.5 ± 3.60 | 0.729 |
Physical activity, Met-min/week | 425 (209–679) | 834 (240–1386) | 0.063 |
Atherogenicity index | |||
Castelli index Ӏ | 3.33 ± 0.79 | 3.65 ± 0.89 | 0.133 |
Triglycerides / HDL-C ratio | 1.33 ± 0.85 | 1.64 ± 1.06 | 0.194 |
AC3 | −0.17 ± 0.48 | 0.01 ± 0.44 | 0.124 |
Castelli index ӀӀ | 1.68 ± 0.48 | 1.80 ± 0.51 | 0.308 |
TyG-Index | 9.02 ± 0.56 | 9.23 ± 0.64 | 0.172 |
AIP | 0.40 ± 0.27 | 0.51 ± 0.24 | 0.109 |
METS-IR | 43.9 ± 9.09 | 45.1 ± 7.14 | 0.576 |
LCI3 | 1.95 ± 0.37 | 2.03 ± 0.40 | 0.382 |